Skip to content

Primary hemiarthroplasty versus conservative treatment for comminuted fractures of the proximal humerus in the elderly - A Multicenter Randomized trial

Primary hemiarthroplasty versus conservative treatment for comminuted fractures of the proximal humerus in the elderly - A Multicenter Randomized trial - ProCon trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41420
Enrollment
65
Registered
2009-06-11
Start date
2009-06-15
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comminutive proximal humeral fractures

Interventions

One group will receive a hemiarthroplasty (Affinis® Fracture shoulder endoprosthesis (Mathys AG Bettlach)). Critical aspects of the surgical procedure will be standardized. After surgery, patients a

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients meeting the following inclusion criteria are eligible for enrolment: 1. Adult men or women aged 65 years and older (with no upper age limit) 2. Fracture of the humeral head 3. Selected three-part (Hertel classification type 9, 10, 11), selected four-part (Hertel type 12), anatomical neck (Hertel type 2), or split-head fractures of the humeral head in the judgement of the attending surgeon. All fractures should be classified according to the binary description system, based on 3D CT reconstructions 4. Operative treatment within 21 days of presenting to the emergency department (if randomized for HA) 5. Provision of informed consent by patient 6. Assurance that the surgeon who will perform HA has attended the pre-trial HA course.

Exclusion criteria

Exclusion criteria: If any of the following criteria applies, patients will be excluded: 1. Polytraumatized patients 2. Patients with an additional traumatic injury of the affected arm 3. Patients with pathological, recurrent or open fractures 4. Patients with an impaired shoulder function (i.e., stiff or painful shoulder, neurologic disorder of the upper limb, or diagnosed rotator cuff impairment) prior to the injury 5. Retained hardware around the affected humerus 6. Patients with a disorder of bone metabolism other than osteoporosis (i.e., Paget*s disease, renal osteodystrophy, osteomalacia) 7. Moderate or severe cognitively impaired patients (i.e., Mini-Mental Status Examination (MMSE) Six Item Screener with 3 or more errors) 8. Likely problems, in the judgment of the investigators, with maintaining follow-up (e.g., patients with no fixed address will be excluded) 9. Insufficient comprehension of the Dutch language to understand a rehabilitation program and other treatment information in the judgment of the attending physician.

Design outcomes

Primary

MeasureTime frame
Constant score

Secondary

MeasureTime frame
DASH score, including optional module for sports/music performance Pain level at both sides (VAS) Secondary intervention Radiographic healing Mortality Complication rates in HA group: infection, neurovascular injury, malpositioning of the prosthesis, asceptic loosening of the prosthesis, dislocation of the tuberculi Complication rates in control group: malunion, nonunion, secondary dislocation, symptomatic avascular necrosis (AVN) of the humeral head SF-36 EQ-5D Costs and cost-effectiveness

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)